The infiltration of DCs in NSCLC is linked to the expression of specific genes like toll‐like receptor 3 (TLR3) and topoisomerase IIα, considering the gene expression characteristics and DC infiltration in NSCLC patients maks it possible to develop effective strategies for treating patients with refractory cancer.102. This evidence concerns the gene TLR3 and non-small cell lung carcinoma.